Boston Scientific Corporation
One Boston Scientific Place
Natick,
MA 01760-1537
United States - Map
Phone: 508-650-8000
Fax: 508-650-8923
Web Site: http://www.bostonscientific.com
| Boston Scientific Corporation operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide. Its products help physicians and other medical professionals improve the patients quality of life by providing alternatives to surgery. The companys cardiovascular group consists of drug-eluting and bare-metal stents, coronary revascularization products, Intraluminal ultrasound imaging catheters and systems, Embolic protection system, peripheral and neurovascular interventions, electrophysiology devices, and cardiac rhythm management devices. This groups products are used to treat cardiovascular, peripheral vascular and neurovascular diseases, cardiac arrhythmias, and neuro and aortic aneurysms. Its endosurgery group includes esophageal, gastric, and duodenal intervention products; colorectal, pancreatico-biliary, and pulmonary intervention devices; and products for urinary tract intervention and bladder disease, prostate intervention, pelvic floor reconstruction and urinary incontinence, and gynecology. This groups products are used for the treatment of gastrointestinal diseases, esophagitis, portal hypertension, peptic ulcers, esophageal cancer, polyps, inflammatory bowel disease, diverticulitis, colon cancer, and benign prostatic hyperplasia. The companys neuromodulation group comprises Precision Spinal Cord Stimulation system for the treatment of chronic pain of the lower back and legs. Its cardiac rhythm management group offers implantable devices used to treat cardiac arrhythmias and heart failure. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Peter Michael Nicholas Jr., 67
Co-Founder and Chairman |
$
210.00K | N/A | Mr. J. Raymond Elliott , 59
Chief Exec. Officer, Pres |
$
69.00K | N/A | Mr. John E. Abele , 72
Co-Founder |
$
69.00K | N/A | Mr. Sam R. Leno , 62
Chief Financial Officer and Exec. VP of Fin. & Information Systems |
$
1.18M |
$
0 | Mr. Fred Colen , 56
Exec. VP and Pres of Cardiac Rhythm Management (CRM) Group |
$
1.03M |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.21% Nasdaq 
Profile
